Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick?

Key PointsModerna's market cap has soared on positive results for its mRNA cancer vaccine.

Leer el informe completo de Veytics

Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.

Registrarse para leer completo Ya tengo una cuenta Abrir fuente original: NASDAQ